Analysis News
In-depth stock market analysis, technical indicators, and investment commentary. Expert insights on market trends, valuations, and trading strategies.
Golar LNG's High Valuation Faces Growth Test Amid $17B Backlog
Golar LNG's contracted backlog supports projected fourfold EBITDA growth by 2028, yet its premium valuation at 74.4x P/E presents significant risk if LNG demand falters.
Lilly's Retevmo Hits Trial Goal in Early Lung Cancer, Stock Reaction Awaited
Eli Lilly announced positive Phase 3 results for Retevmo in early-stage RET fusion-positive non-small cell lung cancer. U.S. market closure delays stock reaction until Tuesday.
Merck Shares Surge to 52-Week High on Deutsche Bank Upgrade
Merck shares climbed to a 52-week high following an upgrade from Deutsche Bank, which raised its price target to $150. The company is set to present new bladder and kidney cancer data later this month.
Vertex Shares Surge on Analyst Upgrade, Pipeline Expansion in Focus
Vertex Pharmaceuticals shares climbed 5.7% following an upgrade from Oppenheimer, driven by its 2026 revenue outlook and expanding pipeline in gene-editing, pain, and kidney therapies.
S&P Global Shares Rally Amid Analyst Target Cuts and Insider Buying
S&P Global shares advanced 3.1% to $409.54 on elevated volume, though remain 29% below their 52-week high. Analysts trimmed price targets but maintained bullish ratings.
Merck Shares Gain on Deutsche Bank Upgrade Ahead of Key Cancer Data
Merck shares advanced following a Deutsche Bank upgrade to Buy and a raised price target, with investors focused on upcoming oncology data at the ASCO GU symposium.
Nuvama Highlights BPCL, Power Grid, SAIL as Key Technical Buys
Analyst Aakash K Hindocha identifies three public sector stocks with strong breakout patterns and defined price targets for February 12, 2026.
Berkshire Hathaway Shares Steady Near $500 as UBS Highlights Defensive Stance, Buyback Doubts
Berkshire Hathaway's Class B shares traded around $500 as UBS emphasized its defensive appeal but noted limited buyback potential. Investors await capital deployment signals from new CEO Greg Abel.
Sheng Siong Stock Slides on OCBC Downgrade Despite Higher Valuation Target
Sheng Siong shares fell sharply after OCBC cut its rating to 'hold', citing elevated valuations ahead of the company's upcoming earnings report, even as the bank raised its price target.
Linde Shares Gain Amid Diverging Analyst Views on Pricing Power
Linde shares rose 1.6% as BMO raised its price target to $507, while DZ Bank downgraded the stock to Hold, highlighting questions over industrial demand.
Booking Holdings Jumps on Analyst Upgrade Ahead of Quarterly Report
Booking Holdings shares gained nearly 3% Tuesday after Gordon Haskett upgraded the stock to Buy with a $5,440 target, recovering from a sharp Monday decline. Investors now focus on the company's upcoming earnings release on February 18.
Flutter Shares Gain Amid Analyst Target Cut and Prediction Market Scrutiny
Flutter Entertainment shares edged higher as UBS reduced its price target while maintaining a Buy rating. Investors await Q4 results and monitor regulatory challenges facing emerging prediction markets.